@article{6b2c8c03be9c4036b23044e8d1fe8306,
title = "2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery",
abstract = "Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity of co-morbidities. MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m2. BMI thresholds should be adjusted in the Asian population such that a BMI >25 kg/m2 suggests clinical obesity, and individuals with BMI >27.5 kg/m2 should be offered MBS. Long-term results of MBS consistently demonstrate safety and efficacy. Appropriately selected children and adolescents should be considered for MBS. (Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013)",
author = "Dan Eisenberg and Shikora, {Scott A.} and Edo Aarts and Ali Aminian and Luigi Angrisani and Cohen, {Ricardo V.} and {de Luca}, Maurizio and Faria, {Silvia L.} and Goodpaster, {Kasey P.S.} and Ashraf Haddad and Himpens, {Jacques M.} and Lilian Kow and Marina Kurian and Ken Loi and Kamal Mahawar and Abdelrahman Nimeri and Mary O{\textquoteright}Kane and Papasavas, {Pavlos K.} and Jaime Ponce and Pratt, {Janey S.A.} and Rogers, {Ann M.} and Steele, {Kimberley E.} and Michel Suter and Kothari, {Shanu N.}",
note = "Publisher Copyright: {\textcopyright} 2022, The Author(s). Published by Elsevier Inc on behalf of American Society for Metabolic & Bariatric Surgery (ASMBS) and Springer Nature on behalf of International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).",
year = "2023",
month = jan,
doi = "10.1007/s11695-022-06332-1",
language = "English (US)",
volume = "33",
pages = "3--14",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer",
number = "1",
}